World Health Organisation

WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug

14 Jan 2008

Kill the killer

By By 2020 one in eight dea | 01 May 2003

View details about the software product Informachine News Trackers